Impact of Intraoperative Macroscopic Diagnosis of Serosal Invasion in Pathological Subserosal (pT3) Gastric Cancer

Dong Jin Kim1, Jun Hyun Lee2, Wook Kim1

  • 1Department of Surgery, Yeouido St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.

Journal of Gastric Cancer
|January 13, 2015
PubMed
Abstract

Insights

Surgeons' gross inspection of serosal invasion in gastric cancer impacts tumor recurrence. Macroscopic findings, especially definite invasion (SE+), are crucial for predicting patient prognosis and guiding treatment decisions.

Area of Science:

  • Surgical Oncology
  • Gastrointestinal Pathology
  • Cancer Prognostics

Background:

  • Macroscopic diagnosis of serosal invasion in gastric cancer can be indistinct during surgery.
  • The prognostic significance of discrepancies between macroscopic and pathological serosal invasion assessments requires further evaluation.

Purpose of the Study:

  • To re-evaluate the prognostic impact of macroscopic serosal invasion diagnosis in gastric cancer.
  • To determine the relationship between intraoperative gross findings and disease-free survival (DFS).

Main Methods:

  • Analysis of 370 locally advanced gastric cancer patients (pT2-pT4a) undergoing curative surgery.
  • Stratification of 155 pT3 patients into serosa exposure (SE) groups: SE(-) (no invasion), SE(±) (ambiguous), and SE(+) (definite invasion).
  • Comparison of clinicopathological features, surgical outcomes, and DFS across groups.

Main Results:

  • Five-year DFS in pT3 patients: 75.1% for SE(-), 68.5% for SE(±), and 39.4% for SE(+) (P<0.05).
  • Macroscopic diagnosis of serosal invasion was an independent risk factor for recurrence (HR for SE(+)=2.45).
  • Lymph node metastasis was also a significant independent risk factor for recurrence.

Conclusions:

  • Intraoperative macroscopic assessment of serosal invasion significantly influences gastric cancer recurrence.
  • Gross appearance of serosal invasion should be incorporated into prognostic predictions for gastric cancer patients.

Related Concept Videos